These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Long-term exposure and safety of lacosamide monotherapy for the treatment of partial-onset (focal) seizures: Results from a multicenter, open-label trial. Vossler DG, Wechsler RT, Williams P, Byrnes W, Therriault S, ALEX-MT study group. Epilepsia; 2016 Oct; 57(10):1625-1633. PubMed ID: 27528101 [Abstract] [Full Text] [Related]
11. Experience with lacosamide in a series of children with drug-resistant focal epilepsy. Guilhoto LM, Loddenkemper T, Gooty VD, Rotenberg A, Takeoka M, Duffy FH, Coulter D, Urion D, Bourgeois BF, Kothare SV. Pediatr Neurol; 2011 Jun; 44(6):414-9. PubMed ID: 21555051 [Abstract] [Full Text] [Related]
12. Efficacy and tolerability of adjuvant lacosamide: The role of clinical characteristics and mechanisms of action of concomitant AEDs. Neal A, D'Souza W, Hepworth G, Lawn N, Cook M, Nikpour A. Epilepsy Behav; 2018 Mar; 80():25-32. PubMed ID: 29396359 [Abstract] [Full Text] [Related]